Kahn-Tan-Faiman Frontiers in Science and Endocrinology Award

Honoring the Legacy of Esteemed Mentors

The Kahn-Tain-Faiman Frontiers in Science and Endocrinology Award was made possible by the generosity of Dr. and Mrs. Sethu K. Reddy and is named for Dr. Reddy’s mentors: Drs. C. Ronald Kahn, Meng Hee Tan, and Charles Faiman.

C. Ronald Kahn, MD, is an internationally recognized expert in diabetes and obesity research, and a preeminent investigator in the area of insulin signal transduction and mechanisms of altered signaling in diabetes and metabolic disease. Dr. Kahn is Chief Academic Officer and Head of the Section on Integrative Physiology and Metabolism at Joslin Diabetes Center and the Mary K. Iacocca Professor of Medicine at Harvard Medical School. Dr. Kahn served as Research Director of Joslin Diabetes Center from 1981 to 2000 and served as President of Joslin Diabetes Center from 2000 to 2007, during which the Center had its greatest growth.

Dr. Kahn has received more than 70 awards and honors, including the Wolf Prize in Medicine, the Kober Medal of the Association of American Physicians, and the highest honors of the American Diabetes Association, U.S. and British Endocrine Societies, Juvenile Diabetes Research Foundation, European Association for the Study of Diabetes and the American Association of Clinical Endocrinologists. He has been elected to the National Academy of Science and National Academy of Medicine. He has authored more than 700 original publications and 200 reviews and chapters and has been recognized as among the world’s most highly cited researchers.

Dr. Kahn holds undergraduate and medical degrees from the University of Louisville. He also holds an honorary Master of Science from Harvard University and honorary Doctorates from the University of Paris, University of Louisville, University of Geneva, Washington University in St. Louis, Louisiana State University and the University of Copenhagen. He is an honorary Professor and Director of the Diabetes Center at Peking University School of Medicine and holds honorary memberships in the British Endocrine Society and Japan Diabetes Society.

Meng Hee Tan, MD, FRCP, FACP, FACE, is an international expert in diabetes - in academia, diabetes organizations, and industry. Currently, Clinical Professor Emeritus of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes in University of Michigan, he was Distinguished Medical Fellow, Lilly Research Laboratories.

Dr. Tan received his MD from Dalhousie University, Halifax, and post-doctoral training from the Joslin Diabetes Center, Harvard University, and in dyslipidemias from UCSF. Returning to his alma mater, he became a leader and physician-scientist.

He published 200+ clinical and basic science papers and book chapters in diabetes, dyslipidemias and endocrinology. His contributions included the insulin action in skeletal muscles, lipoprotein lipase system, pathogenesis of dyslipidemias, and launching pioglitazone and exenatide.

He was the founding Medical Director of the Diabetes Care Program of Nova Scotia that standardized diabetes education programs across the province. A staunch advocate for people with diabetes, he was President of the Canadian Diabetes Association (CDA) and launched numerous national initiatives. He was the inaugural Chair of the Canadian Diabetes Advisory Board and chaired its Expert Panel that developed and implemented the first Clinical Practice Guidelines for Management of Diabetes in Canada. His contributions to diabetes in Canada were recognized by the Medical Research Council and Health & Welfare, Canada.

Internationally, he advised WHO in “Implementing St. Vincent Declaration recommendations in CINDI Countries,” and “Implementing National Diabetes Programs.” He has consulted for South-East Asian nations, Taiwan, and Bermuda. As VP of the International Diabetes Federation (IDF), he chaired the IDF Task Force on Access to Insulin. As consultant to Project HOPE, he helped set up the China Diabetes Education Program.

His many global contributions in diabetes have been recognized by the CDA - Charles H Best Award and Medal, the American Diabetes Association - Harold Rifkin Medal for Distinguished International Service, and the IDF- Honorary Membership.

Charles Faiman, MD, is a former Professor of Physiology and Medicine at the University of Manitoba and former Chairman of the Department of Endocrinology, Diabetes and Metabolism at the Cleveland Clinic Foundation. He is currently a Consultant in the Department. He is a member of numerous societies, having served as President of the Canadian Society of Endocrinology and Metabolism and the Ohio State Chapter of A.A.C.E. He was given the prestigious award of Master of the American College of Endocrinology in 2002. He is listed in “Best Doctors in America”. His extensive research career includes over 170 scientific presentations and over 200 publications. He is an accomplished teacher and well-travelled lecturer in North America, Europe, the Middle and Far East. Dr. Faiman sees himself, most importantly, as a clinical endocrinologist caring for all including Heads of State and government leaders.

Dr. Faiman has been a pioneer in reproductive endocrinology and gonadotropin physiology and is well known and regarded for his original research and wit.